Balanced Outlook on Complaints Overall, the biggest complaints about ColonBroom GLP-1 Booster in 2025 revolve around slow results, pricing, and customer service experiences
Even at doses far exceeding the standard 10 mcg/kg range (scaled to human-equivalent doses of roughly 200-800 mcg/day for a 70-kg adult), researchers have not observed pathological angiogenesis, tumorigenic signaling, or behavioral toxicity 1
It blocks those opioid receptors, so the usual cascade gets muted
Contract manufacturers and suppliers are inspection-readynot just compliant on paper
Moreover, PAS* has immune signaling capacity and induced cytokines IL-1, IL-6, IL-8, IL-10 and TNF- production in human peripheral blood mononuclear cells (PBMCs) [48]